Eric I Benchimol1, Douglas G Manuel, Nassim Mojaverian, David R Mack, Geoffrey C Nguyen, Teresa To, Astrid Guttmann. 1. *Children's Hospital of Eastern Ontario IBD Centre, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada; †Department of Pediatrics, University of Ottawa, Ottawa, Ontario, Canada; ‡School of Epidemiology, Public Health and Preventive Medicine, University of Ottawa, Ottawa, Ontario, Canada; §Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada; ‖Ottawa Hospital Research Institute, Ottawa, Ontario, Canada; ¶Department of Family Medicine, University of Ottawa, Ottawa, Ontario, Canada; **Mount Sinai Centre for Inflammatory Bowel Disease, Mount Sinai Hospital, Toronto, Ontario, Canada; Department of Medicine, University of Toronto, Toronto, Ontario, Canada; ††Child Health Evaluative Sciences, The Hospital for Sick Children, Toronto, Ontario, Canada; Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada; and ‡‡Division of Paediatric Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada; Department of Paediatrics, University of Toronto, Toronto, Ontario, Canada.
Abstract
BACKGROUND: Canada has amongst the highest incidence of inflammatory bowel disease (IBD) in the world, and the highest proportion of immigrants among G8 nations. We determined differences in prediagnosis delay, specialist care, health services use, and risk of surgery in immigrants with IBD. METHODS: All incident cases of IBD in children (1994-2009) and adults (1999-2009) were identified from population-based health administrative data in Ontario, Canada. Linked immigration data identified those who arrived to Ontario after 1985. We compared time to diagnosis, postdiagnosis health services use (IBD specific and related), physician specialist care in immigrants and nonimmigrants, and risk of surgery between immigrants and nonimmigrants. RESULTS: Thousand two hundred two immigrants were compared with 22,990 nonimmigrants. Immigrants had similar time to diagnosis as nonimmigrants for Crohn's (hazard ratio [HR] 1.002; 95% confidence intervals [CIs] 0.89-1.12) and ulcerative colitis (HR 1.073; 95% CI 0.95-1.21). For outpatient visits, immigrants with IBD were seen by gastroenterologists more often than nonimmigrants. Immigrants had greater IBD-specific outpatient health services use after diagnosis (odds ratio 1.24; 95% CI 1.15-1.33), emergency department visits (odds ratio 1.57, 95% CI 1.30-1.91), and hospitalizations (odds ratio 1.19; 95% CI 1.02-1.40). In immigrants, there was lower risk of surgery for Crohn's (HR 0.66, 95% CI 0.43-0.99) and ulcerative colitis (HR 0.52, 95% CI 0.31-0.87). CONCLUSIONS: Immigrants to Canada had greater outpatient and specialty care and lower risk of surgery, with no delay in diagnosis, indicating appropriate use of the health system.
BACKGROUND: Canada has amongst the highest incidence of inflammatory bowel disease (IBD) in the world, and the highest proportion of immigrants among G8 nations. We determined differences in prediagnosis delay, specialist care, health services use, and risk of surgery in immigrants with IBD. METHODS: All incident cases of IBD in children (1994-2009) and adults (1999-2009) were identified from population-based health administrative data in Ontario, Canada. Linked immigration data identified those who arrived to Ontario after 1985. We compared time to diagnosis, postdiagnosis health services use (IBD specific and related), physician specialist care in immigrants and nonimmigrants, and risk of surgery between immigrants and nonimmigrants. RESULTS: Thousand two hundred two immigrants were compared with 22,990 nonimmigrants. Immigrants had similar time to diagnosis as nonimmigrants for Crohn's (hazard ratio [HR] 1.002; 95% confidence intervals [CIs] 0.89-1.12) and ulcerative colitis (HR 1.073; 95% CI 0.95-1.21). For outpatient visits, immigrants with IBD were seen by gastroenterologists more often than nonimmigrants. Immigrants had greater IBD-specific outpatient health services use after diagnosis (odds ratio 1.24; 95% CI 1.15-1.33), emergency department visits (odds ratio 1.57, 95% CI 1.30-1.91), and hospitalizations (odds ratio 1.19; 95% CI 1.02-1.40). In immigrants, there was lower risk of surgery for Crohn's (HR 0.66, 95% CI 0.43-0.99) and ulcerative colitis (HR 0.52, 95% CI 0.31-0.87). CONCLUSIONS: Immigrants to Canada had greater outpatient and specialty care and lower risk of surgery, with no delay in diagnosis, indicating appropriate use of the health system.
Authors: Dalia L Rotstein; Ruth Ann Marrie; Colleen Maxwell; Sima Gandhi; Susan E Schultz; Kinwah Fung; Karen Tu Journal: Neurology Date: 2019-11-05 Impact factor: 9.910
Authors: Hai Yun Shi; Alexander N Levy; Hirsh D Trivedi; Francis K L Chan; Siew C Ng; Ashwin N Ananthakrishnan Journal: Clin Gastroenterol Hepatol Date: 2017-06-08 Impact factor: 11.382
Authors: Alvin Ho-Ting Li; Ahmed A Al-Jaishi; Matthew Weir; Ngan N Lam; Janet Maclean; Sonny Dhanani; S Joseph Kim; Greg Knoll; Amit X Garg Journal: Can J Kidney Health Dis Date: 2017-10-20
Authors: Eric I Benchimol; M Ellen Kuenzig; Charles N Bernstein; Geoffrey C Nguyen; Astrid Guttmann; Jennifer L Jones; Beth K Potter; Laura E Targownik; Christina A Catley; Zoann J Nugent; Divine Tanyingoh; Nassim Mojaverian; Fox E Underwood; Shabnaz Siddiq; Anthony R Otley; Alain Bitton; Matthew W Carroll; Jennifer C deBruyn; Trevor Jb Dummer; Wael El-Matary; Anne M Griffiths; Kevan Jacobson; Desmond Leddin; Lisa M Lix; David R Mack; Sanjay K Murthy; Juan Nicolás Peña-Sánchez; Harminder Singh; Gilaad G Kaplan Journal: Clin Epidemiol Date: 2018-11-08 Impact factor: 4.790
Authors: M Ellen Kuenzig; Eric I Benchimol; Lawrence Lee; Laura E Targownik; Harminder Singh; Gilaad G Kaplan; Charles N Bernstein; Alain Bitton; Geoffrey C Nguyen; Kate Lee; Jane Cooke-Lauder; Sanjay K Murthy Journal: J Can Assoc Gastroenterol Date: 2018-11-02
Authors: M Ellen Kuenzig; Therese A Stukel; Gilaad G Kaplan; Sanjay K Murthy; Geoffrey C Nguyen; Robert Talarico; Eric I Benchimol Journal: J Can Assoc Gastroenterol Date: 2020-01-23
Authors: Eric I Benchimol; Frances Tse; Matthew W Carroll; Jennifer C deBruyn; Shelly A McNeil; Anne Pham-Huy; Cynthia H Seow; Lisa L Barrett; Talat Bessissow; Nicholas Carman; Gil Y Melmed; Otto G Vanderkooi; John K Marshall; Jennifer L Jones Journal: J Can Assoc Gastroenterol Date: 2021-07-29
Authors: Gilaad G Kaplan; Eric I Benchimol; M Ellen Kuenzig; Mohsen Sadatsafavi; J Antonio Aviña-Zubieta; Rebecca M Burne; Michal Abrahamowicz; Marie-Eve Beauchamp Journal: Clin Epidemiol Date: 2018-07-12 Impact factor: 4.790
Authors: Aman K Dheri; M Ellen Kuenzig; David R Mack; Sanjay K Murthy; Gilaad G Kaplan; Jessy Donelle; Glenys Smith; Eric I Benchimol Journal: J Crohns Colitis Date: 2021-12-18 Impact factor: 9.071